Home > Analytics > NURECA

NURECA
Intrinsic Value | Fundamental Analysis

BOM : 543264     NSE : NURECA    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : NA
Sep 28,2022
Price(EOD): ₹ 866.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Trading
MCap: ₹ 866.10 Cr
Value of ₹ 1 Lac invested in NURECA
on Feb 25,2021 (price: ₹ 666.65)

₹ 1 L

₹ 1.30 L

1W : -10.5% 1M : -12.8% 1Y : -45.3%
COMMUNITY POLL
for NURECA
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
NURECA -10.5% -12.8% -45.3%
ADANI TRANSMISSION -10% -6.5% 134.6%
ADANI ENTERPRISES -4.5% 12.9% 143.5%
SUNDRAM FASTENERS -5.6% 4.4% -3.6%
REDINGTON (INDIA) -3.6% -6% -0.9%
MMTC -6.6% -22.7% -18.6%
NOVARTIS INDIA -3.8% -10% -18.1%
MSTC -12.4% -6.7% -16.6%
SVP GLOBAL VENTURES -6.7% -9.5% -72%

FUNDAMENTAL ANALYSIS OF NURECA

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF NURECA

 
Valuation Score
[As on : Sep 28,2022 ]

Ratio Consolidated
P/E
P/B
P/S
186.87
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 4.64 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

4.26
P/B Calculated based on Book Value of Rs 203.20 Cr
[Latest Year - Mar2022 - Consolidated Results ]

5.36
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 161.59 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF NURECA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
393582%
NA (-ve EV)
-

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF NURECA



NURECA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF NURECA

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.01
0.01
0.69
0.24
0.01
0.01
0.7
0.24
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF NURECA

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF NURECA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-37.81%
-109.24%
-178.22%
-194.09%
-78.63%
-112.17%
-110.85%
-111.41%
QtrlyTrend
-8
Latest Qtr: Jun2022
Quarterly Result Analysis →


NURECA related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -1% 0.6% -13.9%
S&P BSE SMALL CAP -4.7% -1.9% -0.9%
S&P BSE ALLCAP -4.9% -3.4% -3.3%
S&P BSE MIDSMALLCAP -4.9% -2.3% -2.4%
No NSE index found

You may also like the below Video Courses


FAQ about NURECA


Is NURECA good for long term investment?

As on Sep 28,2022, the Fundamentals of NURECA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NURECA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NURECA UnderValued or OverValued?

As on Sep 28,2022, NURECA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of NURECA ?

As on Sep 28,2022, the Intrinsic Value of NURECA is Rs. 0.22 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 0.22
Fair Value [Median EV / Sales Model] : Rs. -0.02
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of NURECA : Rs. 0.22

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is NURECA trading at a Premium or Discount?

As on Sep 28,2022, NURECA is trading at a Premium of 394631% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].